Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database Meeting Abstract


Authors: Ou, F. S.; Lou, Y.; Van Cutsem, E.; Saltz, L.; Schmoll, H. J.; Goldberg, R. M.; Hoff, P.; Douillard, J. Y.; Hecht, J. R.; Hurwitz, H.; Punt, C. J. A.; Bokemeyer, C.; Fuchs, C. S.; Diaz-Rubio, E.; Tebbut, N.; Falcone, A.; Kabbinavar, F. F.; De Gramont, A.; Grothey, A.; Shi, Q.
Abstract Title: Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database
Meeting Title: 2018 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 4 Suppl.
Meeting Dates: 2018 Jan 18-20
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000436174100588
PROVIDER: wos
DOI: 10.1200/JCO.2018.36.4_suppl.612
Notes: Meeting Abstract: 612 -- Source: Wos
Altmetric Score
MSK Authors
  1. Leonard B Saltz
    560 Saltz